1.A Case of Suspected Danon Disease Presenting as a Hypertrophic Cardiomyopathy.
So Yeon PARK ; Dae Gyun PARK ; Hyun Hee CHOI ; Duck Hyoung YOON ; Sung Eun KIM ; Jun Hee LEE ; Kyoo Rok HAN ; Dong Jin OH
Journal of Cardiovascular Ultrasound 2009;17(1):28-30
Danon disease is characterized clinically by the triad of cardiomyopathy, myopathy and mental retardation. It was originally reported as a lysosomal glycogen storage disease with normal acid maltase by Danon. Danon disease results from mutations in lysosome associated membrane protein-2 (LAMP-2) gene. The LAMP-2 gene is located on Xq24-25. We report a case of suspected Danon disease in patient who had hypertrophic cardiomyopathy and mental retardation along with abnormal findings in electromyography.
alpha-Glucosidases
;
Cardiomyopathies
;
Cardiomyopathy, Hypertrophic
;
Glycogen Storage Disease
;
Glycogen Storage Disease Type IIb
;
Humans
;
Intellectual Disability
;
Lysosomes
;
Membranes
;
Muscular Diseases
3.Clinical characteristics of Danon disease.
Wu Wan WANG ; Yuan Yuan ZHU ; Wei WU ; Da Chun ZHAO ; Xue LIN ; Li Gang FANG ; Shu Yang ZHANG
Chinese Journal of Cardiology 2023;51(1):51-57
Objective: To review the clinical data of 7 patients with Danon disease and analyze their clinical characteristics. Methods: The medical records of 7 patients with Danon disease, who were hospitalized in Peking Union Medical College Hospital of Chinese Academy of Medical Sciences from April 2008 to July 2021, were reviewed and summarized, of which 6 cases were diagnosed as Danon disease by lysosomal-associated membrane protein-2 (LAMP-2) gene mutation detection and 1 case was diagnosed by clinicopathological features. Clinical manifestations, biochemical indexes, electrocardiogram, echocardiography, skeletal muscle and myocardial biopsy and gene detection results were analyzed, and patients received clinical follow-up after discharge. Results: Six patients were male and average age was (15.4±3.5) years and the average follow-up time was (27.7±17.0) months. The main clinical manifestations were myocardial hypertrophy (6/7), decreased myodynamia (2/7) and poor academic performance (3/7). Electrocardiogram features included pre-excitation syndrome (6/7) and left ventricular hypertrophy (7/7). Echocardiography examination evidenced myocardial hypertrophy (6/7), and left ventricular dilatation and systolic dysfunction during the disease course (1/7). The results of skeletal muscle biopsy in 6 patients were consistent with autophagy vacuolar myopathy. Subendocardial myocardial biopsy was performed in 3 patients, and a large amount of glycogen deposition with autophagosome formation was found in cardiomyocytes. LAMP-2 gene was detected in 6 patients, and missense mutations were found in all these patients. During the follow-up period, implantable cardioverter defibrillator implantation was performed in 1 patient because of high atrioventricular block 4 years after diagnosis, and there was no death or hospitalization for cardiovascular events in the other patients. Conclusion: The main clinical manifestations of Danon disease are cardiomyopathy, myopathy and mental retardation. Pre-excitation syndrome is a common electrocardiographic manifestation. Autophagy vacuoles can be seen in skeletal muscle and myocardial pathological biopsies. LAMP-2 gene mutation analysis is helpful in the diagnose of this disease.
Adolescent
;
Child
;
Female
;
Humans
;
Male
;
Cardiomyopathies/etiology*
;
Glycogen Storage Disease Type IIb/complications*
;
Hypertrophy, Left Ventricular/etiology*
;
Lysosomal-Associated Membrane Protein 2/genetics*
;
Pre-Excitation Syndromes/genetics*
4.Heart Disease in Disorders of Muscle, Neuromuscular Transmission, and the Nerves.
Josef FINSTERER ; Claudia STÖLLBERGER
Korean Circulation Journal 2016;46(2):117-134
Little is known regarding cardiac involvement (CI) by neuromuscular disorders (NMDs). The purpose of this review is to summarise and discuss the major findings concerning the types, frequency, and severity of cardiac disorders in NMDs as well as their diagnosis, treatment, and overall outcome. CI in NMDs is characterized by pathologic involvement of the myocardium or cardiac conduction system. Less commonly, additional critical anatomic structures, such as the valves, coronary arteries, endocardium, pericardium, and even the aortic root may be involved. Involvement of the myocardium manifests most frequently as hypertrophic or dilated cardiomyopathy and less frequently as restrictive cardiomyopathy, non-compaction, arrhythmogenic right-ventricular dysplasia, or Takotsubo-syndrome. Cardiac conduction defects and supraventricular and ventricular arrhythmias are common cardiac manifestations of NMDs. Arrhythmias may evolve into life-threatening ventricular tachycardias, asystole, or even sudden cardiac death. CI is common and carries great prognostic significance on the outcome of dystrophinopathies, laminopathies, desminopathies, nemaline myopathy, myotonias, metabolic myopathies, Danon disease, and Barth-syndrome. The diagnosis and treatment of CI in NMDs follows established guidelines for the management of cardiac disease, but cardiotoxic medications should be avoided. CI in NMDs is relatively common and requires complete work-up following the establishment of a neurological diagnosis. Appropriate cardiac treatment significantly improves the overall long-term outcome of NMDs.
Arrhythmias, Cardiac
;
Cardiomyopathies
;
Cardiomyopathy, Dilated
;
Cardiomyopathy, Restrictive
;
Coronary Vessels
;
Death, Sudden, Cardiac
;
Diagnosis
;
Endocardium
;
Glycogen Storage Disease Type IIb
;
Heart Arrest
;
Heart Diseases*
;
Heart*
;
Muscular Diseases
;
Myocardium
;
Myopathies, Nemaline
;
Myotonia
;
Neuromuscular Diseases
;
Pericardium
;
Tachycardia, Ventricular
5.Identification of LAMP2 mutations in early-onset hypertrophic cardiomyopathy by targeted exome sequencing.
Inkyu GILL ; Ja Hye KIM ; Jin Hwa MOON ; Yong Joo KIM ; Nam Su KIM
Journal of Genetic Medicine 2018;15(2):87-91
X-linked dominant mutations in lysosome-associated membrane protein 2 (LAMP2) gene have been shown to be the cause of Danon disease, which is a rare disease associated with clinical triad of cardiomyopathy, skeletal myopathy, and mental retardation. Cardiac involvement is a common manifestation and is the leading cause of death in Danon disease. We report a case of a 24-month-old boy with hemizygous LAMP2 mutation who presented with failure to thrive and early-onset hypertrophic cardiomyopathy. We applied targeted exome sequencing and found a novel hemizygous c.692del variant in exon 5 of the LAMP2 gene, resulting a frameshift mutation p.Thr231Ilefs*11. Our study indicates that target next-generation sequencing can be used as a fast and highly sensitive screening method for inherited cardiomyopathy.
Cardiomyopathies
;
Cardiomyopathy, Hypertrophic*
;
Cause of Death
;
Child, Preschool
;
Exome*
;
Exons
;
Failure to Thrive
;
Frameshift Mutation
;
Glycogen Storage Disease Type IIb
;
Humans
;
Intellectual Disability
;
Lysosomal-Associated Membrane Protein 2
;
Male
;
Mass Screening
;
Membrane Proteins
;
Methods
;
Muscular Diseases
;
Rare Diseases